Announcements Trials
Browse Landscape

Status

Unknown 4Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 1387Neoplasms 1164Colorectal Neoplasms 624Lung Neoplasms 559Prostatic Neoplasms 538Carcinoma, Non-Small-Cell Lung 443Carcinoma, Hepatocellular 296Stomach Neoplasms 272Pancreatic Neoplasms 270Colonic Neoplasms 264Ovarian Neoplasms 230Head and Neck Neoplasms 228Rectal Neoplasms 221Melanoma 215Multiple Myeloma 202Uterine Cervical Neoplasms 198Lymphoma 195Leukemia 193Precursor Cell Lymphoblastic Leukemia-Lymphoma 191Neoplasm Metastasis 178Carcinoma, Renal Cell 177Esophageal Neoplasms 173Brain Neoplasms 173Leukemia, Myeloid, Acute 158Urinary Bladder Neoplasms 138Recurrence 123Polycystic Ovary Syndrome 122Liver Neoplasms 118Hematologic Neoplasms 117Endometrial Neoplasms 107

Interventions

acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Observational × Advanced Prostate Cancer × Clear all
NCT02234089 2019-07-05

ProComD

Ferring Pharmaceuticals

Completed
461 enrolled
Genitourinary

Advanced Prostate Cancer

NCT01383863 2019-01-14

TRIPTOCARE LT

Ipsen

Completed
180 enrolled
Genitourinary

Advanced Prostate Cancer

NCT00871585 2010-04-15

Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide

AstraZeneca

Completed
340 enrolled
Genitourinary

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡